Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2008
10/15/2008EP1980305A1 Apparatus and method for the isolation of produced particles as a suspension in a non-supercritical fluid
10/15/2008EP1980304A1 Apparatus and method for the isolation of produced particles as a suspension in a non-supercritical fluid
10/15/2008EP1980278A2 Drug coating with top coat
10/15/2008EP1980272A2 Orally-disintegrating tablet and manufacturing method thereof
10/15/2008EP1980271A1 Medicine for transnasal administration
10/15/2008EP1980263A1 Combinations of immunosuppressive agents for the treatment or prevention of graft rejections
10/15/2008EP1980256A1 OIL-IN-WATER TYPE EMULSION LOTION CONTAINING 22-OXA-1 alpha ,25-DIHYDROXYVITAMIN D3 AND METHOD OF TREATING SKIN DISEASE BY USING THE SAME
10/15/2008EP1980253A1 Use of meloxicam formulations in veterinary medicine
10/15/2008EP1980252A2 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
10/15/2008EP1980245A1 Bilayer lyophilized pharmaceutical compositions and methods of making and using same
10/15/2008EP1980244A2 Basis particles and orally-disintegrating tablet containing them
10/15/2008EP1980243A1 Liposome preparation
10/15/2008EP1980242A1 Compositions comprising drospirenone moleculary dispersed
10/15/2008EP1980241A2 Wet wipes with vitex agnus castus extract for feminine personal care
10/15/2008EP1980240A1 Lyophilized pharmaceutical compositions and methods of making and using same
10/15/2008EP1979269A2 Chlorite formulations, and methods of preparation and use thereof
10/15/2008EP1979043A1 System and apparatus for controlled activation of acute use medical devices
10/15/2008EP1978997A1 Transdermal delivery of pharmaceutical agents
10/15/2008EP1978996A2 Small-volume oral transmucosal dosage forms
10/15/2008EP1978956A1 Complex formulation comprising amlodipine camsylate and simvastatin and method for preparation thereof
10/15/2008EP1978953A1 Pharmaceutical compositions containing docetaxel and a degradation inhibitor and a process for obtaining the same.
10/15/2008EP1978950A2 Pharmaceutical sustained release compositions comrising in particular thyroid hormones
10/15/2008EP1978946A2 Nanoparticles designed for drug delivery
10/15/2008EP1978945A1 Method for producing a particle comprising a gas core and a shell and particles thus obtained
10/15/2008EP1978944A2 Soft-gelatin capsule formulation
10/15/2008EP1978943A1 Chewable capsules
10/15/2008EP1978942A1 Compositions containing solid ibuprofen concentrates and methods of making solid ibuprofen concentrates
10/15/2008EP1978941A2 Biodegradable non-ophthalmic implants and related methods
10/15/2008EP1978940A2 Biologically active composition comprising ethylcellulose
10/15/2008EP1978939A2 Mouth dissolving pharmaceutical composition and process for preparing the same using a high amount of silicon dioxine
10/15/2008EP1978938A1 Process for loading polymer particles with drug
10/15/2008EP1978937A1 Use of amphiphilic self-assembling proteins for formulating poorly water-soluble effect substances
10/15/2008EP1978936A1 Pharmaceutical compositions containing mixtures of polymers and active agents poorly soluble in water
10/15/2008EP1978935A1 Coated formulations
10/15/2008EP1978934A1 Bursting pellets
10/15/2008EP1978933A2 Processes for making particle-based pharmaceutical formulations for oral administration
10/15/2008EP1978932A1 Water stabilized aerosol formulation system and method of making
10/15/2008EP1978931A1 Composition for promoting vascular smooth muscle relaxation
10/15/2008EP1978930A2 Sutures and anti-scarring agents
10/15/2008EP1978929A1 Emulsion
10/15/2008EP1978928A1 Pharmaceutical composition and process
10/15/2008EP1978927A1 Pharmaceutical forms in film form for use in the mouth (wafer)
10/15/2008EP1978926A2 Topical mecamylamine formulations for ocular administration and uses thereof
10/15/2008EP1978925A1 Thermosetting neutralized chitosan composition forming a hydrogel, lyophilizate, and processes for producing the same
10/15/2008EP1978808A2 Method of reversing, preventing, delaying or stabilizing soft tissue calcification
10/15/2008EP1838293B1 Two-piece capsule comprising a preliminary closure for accommodating pharmaceutical preparations for powder inhalers
10/15/2008EP1838284A4 Nanoparticles for delivery of therapeutic agents using ultrasound and associated methods
10/15/2008EP1713505B1 Method of preparation of a fungal glucane hydrogel having antibacterial and immunostimulant activity, and use thereof
10/15/2008EP1628655A4 Antiseptic compositions, methods and systems
10/15/2008EP1589952B1 Long-lasting, flavored dosage forms for sustained release of beneficial agents within the mouth
10/15/2008EP1581286B1 Permeable membrane catheters, systems, and methods
10/15/2008EP1581284B1 Implantable drug delivery systems
10/15/2008EP1569623B1 A topical nanoparticulate spironolactone formulation
10/15/2008EP1480614B1 Emulsion containing hydrophobic nanodrops with bound hemoglobin molecules in a hydrophilic phase as a blood substitute
10/15/2008EP1474105B1 Medicated tampon
10/15/2008EP1429712B1 Method for treating bronchial constriction and bronchospasm
10/15/2008EP1415663B1 Sustained release hgf hydrogel preparations
10/15/2008EP1387670B1 Immune modulation device for use in animals
10/15/2008EP1385478B1 Method for applying an active ingredient to a substrate, compositions for said method, container containing a composition and use of said compositions
10/15/2008EP1383786B1 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
10/15/2008EP1379207A4 Composition for freshening nostrils and sinus cavities
10/15/2008EP1377274B1 Drug delivery system for photosensitizers
10/15/2008EP1341556B1 Drug delivery system
10/15/2008EP1233980B1 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence
10/15/2008EP1200129B1 Taste masking of oral quinolone liquid preparations using ion exchange resins
10/15/2008EP1197265B1 Powder material spraying device
10/15/2008EP1126826B1 Multiparticulate modified release composition of methylphenidate
10/15/2008EP1083882B1 Poly-l-lysine grafted with lactose or galactose-polyethylene glycol as polymeric gene carrier
10/15/2008EP0841946B2 Methods for treatment of allergic asthma
10/15/2008CN201131931Y Pressing prepared traditional Chinese medicine or traditional Chinese medicinal materials
10/15/2008CN101287495A Direct compression formulation of DPP-IV inhibitors and glitazones, and process
10/15/2008CN101287477A Composition containing nano grain of silver and application thereof
10/15/2008CN101287473A Agent for applying to mucosa and method for production thereof
10/15/2008CN101287470A Improved testosterone gel and method of use
10/15/2008CN101287466A Immediate release therapeutic systems for improved oral absorption of 7-[(E)-t-butyloxyminomethyl] camptothecin
10/15/2008CN101287463A New pharmaceutical compositions comprising 4-(4-(3-(4-chloro-3-trifluoromethyl-phenyl)-ureido)-3-fluoro-phenoxy)-pyridine-2-carboxylic acid for the treatment of hyper-proliferative disorders
10/15/2008CN101287454A Iontophoresis preparation for treatment of breast cancer and/or mastitis
10/15/2008CN101287453A Nanoparticulate and controlled release compositions comprising a cephalosporin
10/15/2008CN101287452A Solid pharmaceutical compositions comprising 1-(4-chloroanilino)-4-(4-pyridylmethyl) phthalazine and a ph modifier
10/15/2008CN101287451A Nanoparticulate and controlled release compositions comprising a platelet aggregation inhibitor
10/15/2008CN101287450A Method for production of directly compressible ibuprofen formulations
10/15/2008CN101287449A Preservation of bioactive materials by spray drying
10/15/2008CN101287448A Microparticle compositions of the topoisomerase i inhibitor 7-tert-butoxyiminomethylcamptothecin
10/15/2008CN101287447A Aqueous anaesthetic propofol composition comprising propofol
10/15/2008CN101287446A Antibiotic formulations, unit doses, kits, and methods
10/15/2008CN101287445A Oral, rapidly disintegrating film, which cannot be spat out, for a neuroleptic
10/15/2008CN101287444A Oral, quickly disintegrating film, which cannot be spit out, for an antiemetic or antimigraine agent
10/15/2008CN101287443A Pulse releasing system controlled by pH, preparation method and application thereof
10/15/2008CN101287411A Pharma-informatics system
10/15/2008CN101287381A Stable, durable granules with active agents
10/15/2008CN101284137A Nm gene formulations for promoting mink growing
10/15/2008CN101284136A Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier
10/15/2008CN101284133A Drug carried target cationic polymer for injections and modified by integrin ligand
10/15/2008CN101284132A Application of high molecule absorbent resin in medicine for external application and application process thereof
10/15/2008CN101284131A Application of cyanoacrylate glycol ester in preparing medicine carrier
10/15/2008CN101284128A Medicine for relieving or neutralizing the effect of alcohol and resisting intoxication and preparation method thereof
10/15/2008CN101284126A Attapulgite kibe chrisma
10/15/2008CN101284123A Yanghe decoction oral formulations and preparation method thereof
10/15/2008CN101284120A Process for preparing Pingxiao preparation
10/15/2008CN101284119A Compound antitoxic pill
1 ... 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 ... 2991